 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Foundation for Innovative New Diagnostics (FIND) |
| Street 1: | Campus Biotech, Chemin des Mines 9 |
| Street 2: | |
| City: | Geneva |
| Province: | |
| Post Code: | 1202 |
| Country: | Switzerland |
| Phone: | 41 (22) 710 05 90 |
| Organization Email: | info@finddx.org |
| Web Site: | http://www.finddx.org/ |
| Other Online Presence: | Twitter, Facebook |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 0000 |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| FIND is a global non-profit organization that drives innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations. Diagnostics often do not exist, are inaccessible, or cost too much. Despite being pivotal for guiding the best treatment for individual patients; for preventing the spread of disease and antimicrobial resistance; and for enhancing surveillance for early disease detection and monitoring – diagnostics remain under-resourced and overlooked. Diagnosing TB remains a major challenge. The “gold standard” test is smear microscopy, which misses too many cases. Simpler and more sensitive TB tests are urgently needed to avoid missing TB cases and to more easily diagnose TB in health facilities with limited laboratory infrastructure. We have been involved in development and/ or delivery of every one of the 10 TB diagnostics recommended by WHO. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Delivery of health services and care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 6 - 10 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | NA |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Not Applicable | |
Geographical Reach | |
| Which country is your headquarters located in: | Switzerland |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
India South Africa Switzerland Uganda Viet Nam |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: FIND is committed to fighting the continued spread of TB drug resistance and improving patient care. Drug susceptibility tests (DST) are a key component of both. FIND is working to promote universal DST through the development of affordable tests for use in both centralized and decentralized settings in low- and middle-income countries. New Diagnostics: Since 2003, FIND has promoted improvements in TB diagnostics and accelerated access to new diagnostic tools by working directly with health ministries to develop locally appropriate solutions based on international best practices. FIND’s strategic approach for TB from 2015-2020 builds on this work and is guided by a vision of the future in which all people affected by TB have access to fit-for-purpose diagnostics and are linked to treatment. In pursuit of this vision, FIND’s activities are focused around four key objectives: •Cutting transmission through early detection •Providing correct treatment through early drug susceptibility testing (DST), preventing antimicrobial resistance and decreased morbidity and mortality •Maximizing the impact of available TB diagnostics through comprehensive, country-specific solutions •Demonstrating the vital role of diagnostics in controlling TB These activities are conducted with a wide range of partners from companies, academic and research institutions, international organizations, health ministries and civil society organizations. Research: FIND has created a range of resources for researchers and developers, including: •Specimen bank •Strain bank •Virtual strain bank •Developer’s Toolset |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | January 23, 2019 |
| Last updated: | February 22, 2019 |